APOE and dementia: The proportion of APOE4 carriers ranged from 20% (142/700) in HAAS to 36% (81/227) in CC75C and the proportion of individuals with dementia ranged from 47% (827/1749) in ROSMAP to 66% (360/548) in HAAS (table).